Trial NCT00924664

View at ClinicalTrials.gov 
Org. Study IDs: A4091039
Secondary IDs: CLBP SAFETY EXTENSION OF 1012

Last trial update was posted on 2021-04-21

MeSH Interventions

Tanezumab

MeSH Conditions

Back Pain Low Back Pain

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to FDA-imposed clinical hold, further study drug dosing stopped prematurely and study was terminated. Designation of outcomes as primary, secondary based on study team input as study did not specify them as primary or secondary.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID